Patents by Inventor Jacob Erstling

Jacob Erstling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12188939
    Abstract: Methods of obtaining and kits that can be used to obtain an optical super-resolution image of a sample or a portion thereof or an individual or a portion thereof. In various examples, the individual is an individual with cancer. In various examples, a method includes contacting a sample or individual with one or more aluminosilicate nanoparticle(s) that have at least one organic fluorophore molecule covalently bonded to the aluminosilicate network of the nanoparticle(s), or a composition including the aluminosilicate nanoparticle(s); irradiating the sample or the individual, thereby exciting at least one of the fluorophore molecules of an individual aluminosilicate nanoparticle; and obtaining a fluorescence image or a sequence of fluorescence images, which can be processed to obtain a super-resolution image of the sample or the individual. In various examples, the sample is a biological sample, living or fixed tissues and/or cells, or a biopsy obtained from an individual.
    Type: Grant
    Filed: October 14, 2021
    Date of Patent: January 7, 2025
    Assignee: Cornell University
    Inventors: Jacob Erstling, Joshua A. Hinckley, Nirmalya Bag, Ulrich B. Wiesner
  • Publication number: 20240219393
    Abstract: Methods of determining the presence or absence or local concentration of an analyte in a sample or an individual or a portion thereof using ratiometric sensing and optical super-resolution microscopy (OSRM). The methods use aluminosilicate nanoparticles that can be used in OSRM. The analytes can be biologically relevant analytes, such as, for example, biologically relevant hydrogen ions, oxygen, reactive oxygen species, anions, nitric oxide, metal ions, anions, etc. The methods utilize averaging to address aluminosilicate nanoparticle homogeneity. The methods can be used in methods of treatment.
    Type: Application
    Filed: April 15, 2022
    Publication date: July 4, 2024
    Inventors: Rachel Lee, Jacob Erstling, Joshua Hinckley, Ulrich B. Wiesner
  • Publication number: 20220113315
    Abstract: Methods of obtaining and kits that can be used to obtain an optical super-resolution image of a sample or a portion thereof or an individual or a portion thereof. In various examples, the individual is an individual with cancer. In various examples, a method includes contacting a sample or individual with one or more aluminosilicate nanoparticle(s) that have at least one organic fluorophore molecule covalently bonded to the aluminosilicate network of the nanoparticle(s), or a composition including the aluminosilicate nanoparticle(s); irradiating the sample or the individual, thereby exciting at least one of the fluorophore molecules of an individual aluminosilicate nanoparticle; and obtaining a fluorescence image or a sequence of fluorescence images, which can be processed to obtain a super-resolution image of the sample or the individual. In various examples, the sample is a biological sample, living or fixed tissues and/or cells, or a biopsy obtained from an individual.
    Type: Application
    Filed: October 14, 2021
    Publication date: April 14, 2022
    Inventors: Jacob Erstling, Joshua A. Hinckley, Nirmalya Bag, Ulrich B. Wiesner
  • Publication number: 20210030675
    Abstract: The present disclosure is directed to methods of producing monosized protocells from monosized mesoporous silica nanoparticles (mMSNPs) and their use for targeted drug delivery formulations and systems and for biomedical applications. The present disclosure is also directed in part to a multilamellar or unilamellar protocell vaccine to deliver full length viral protein and/or plasmid encoded viral protein to antigen presenting cells (APCs) in order to induce an immunogenic response to a virus.
    Type: Application
    Filed: March 24, 2020
    Publication date: February 4, 2021
    Inventors: C. Jeffrey Brinker, Paul N. Durfee, Jason Townson, Yu-Shen Lin, Stanley Shihyao Chou, Jacob Erstling
  • Publication number: 20180344641
    Abstract: The present disclosure is directed to methods of producing monosized protocells from monosized mesoporous silica nanoparticles (mMSNPs) and their use for targeted drug delivery formulations and systems and for biomedical applications. The present disclosure is also directed in part to a multilamellar or unilamellar protocell vaccine to deliver full length viral protein and/or plasmid encoded viral protein to antigen presenting cells (APCs) in order to induce an immunogenic response to a virus.
    Type: Application
    Filed: September 2, 2016
    Publication date: December 6, 2018
    Inventors: C. Jeffrey Brinker, Paul N. Durfee, Jason Townson, Yu-Shen Lin, Stanley Shihyao Chou, Jacob Erstling